M. Jurimaromet et al., INDUCTION OF CYP3A AND ASSOCIATED TERFENADINE N-DEALKYLATION IN RAT HEPATOCYTES COCULTURED WITH 3T3 CELLS, Cell biology and toxicology, 11(6), 1995, pp. 313-327
Long-term culture of hepatocytes has been challenged by the loss of di
fferentiated functions. In particular, there is a rapid decline in cyt
ochrome P450 (CYP). In this study, we cocultured rat hepatocytes with
3T3 fibroblasts for 10 days, and examined hepatocyte viability, morpho
logy, and expression of CYP3A. Terfenadine was incubated with the cult
ures, and its biotransformation was quantitatively analyzed by HPLC. T
erfenadine is metabolized by two major pathways: C-hydroxylation to an
alcohol metabolite which is further oxidized to a carboxylic acid, an
d N-dealkylation to azacyclonol. In rat liver, only the N-dealkylation
pathway appears to be mediated by CYP3A since anti-rat CYP3A antibody
inhibited azacyclonol but not alcohol metabolite formation in incubat
ions of terfenadine with liver microsomes. Freshly isolated rat hepato
cytes were seeded on top of confluent 3T3 cells. Cultures were maintai
ned in Williams' E medium supplemented with 10% fetal bovine serum and
either 0.1 mu mol/L or 5 mu mol/L dexamethasone. In pure hepatocyte c
ultures, viability, as determined by lactate dehydrogenase (LDH) activ
ity, decreased steadily to less than 30% of initial levels by day 10.
In cocultures, LDH activity remained high and was 70% of initial level
s on day 10. The half-life of terfenadine disappearance was optimally
maintained in cocultures treated with 5 mu mol/L dexamethasone, and wa
s associated with the increased formation of azacyclonol. On day 5, ne
arly 50% of added 5 mu mol/L terfenadine was converted to azacyclonol
within 6 h, whereas the conversion was only 4% on day 1. Western and R
NA-slot blot analyses confirmed that treatment with 5 mu mol/L dexamet
hasone induced CYP3A mRNA expression and CYP3A protein expression. Thi
s coculture system could offer a useful approach in the study of drugs
and xenobiotics metabolized by CYP3A.